Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action

Diabetes Care

Volumn 35, Issue 5, 2012, Pages 1090-1094

  Brandman, Danielle ^a   Bacchetti, Peter ^a   Ayala, Claudia E ^a   Maher, Jacquelyn J ^a,b   Khalili, Mandana ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; OCTREOTIDE; PEGINTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; GENOTYPE; GLUCOSE METABOLISM; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HORMONE ACTION; HORMONE INHIBITION; HUMAN; INFECTION CONTROL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MICROBIOLOGICAL PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; SUSTAINED VIROLOGIC RESPONSE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; FEMALE; GLUCOSE; HEPACIVIRUS; HEPATITIS C; HUMANS; INSULIN RESISTANCE; INTERFERONS; MALE; MIDDLE AGED; RIBAVIRIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862059747     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1837     Document Type: Article

References (29)

1. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-333 (Pubitemid 29088433)
2. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592-599
3. Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003;38:50-56 (Pubitemid 36775795)
4. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008;47:2127-2133 (Pubitemid 351945577)
5. Delgado-Borrego A, Kamegaya Y, Jordan SH, Agrawal S, Valim C, Chung RT. HCV synergizes with body weight in the promotion of insulin resistance. J Viral Hepat 2011;18:135-141
6. Kawaguchi T, Ide T, Taniguchi E, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007;102:570-576 (Pubitemid 46328143)
7. Romero-Gómez M, Fernández-Rodríguez CM, Andrade RJ, et al. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. J Hepatol 2008;48:721-727
8. Giordanino C, Bugianesi E, Smedile A, et al. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am J Gastroenterol 2008;103:2481-2487
9. D'Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005;100:1509-1515 (Pubitemid 41032355)
10. Petta S, Cammà C, Di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 2008;103:1136-1144 (Pubitemid 351677995)
11. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected in: Gastroenterology 2004;126:634]. Gastroenterology 2003;125:1695-1704 (Pubitemid 37500434)
12. Khattab M, Eslam M, Sharwae MA, Shatat M, Ali A, Hamdy L. Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients. Am J Gastroenterol 2010;105:1970-1977
13. Grasso A, Malfatti F, De Leo P, et al. Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin. J Hepatol 2009;51:984-990
14. Moucari R, Ripault MP, Martinot-Peignoux M, et al. Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut 2009;58:1662-1669
15. Poustchi H, Negro F, Hui J, et al. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. J Hepatol 2008;48:28-34 (Pubitemid 350191982)
16. Romero-Gómez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005;128:636-641
17. Lam KD, Bacchetti P, Abbasi F, et al. Comparison of surrogate and directmeasurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Hepatology 2010;52:38-46
18. Park SK, Cho YK, Park JH, et al. Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity: a 5-year prospective follow-up study variation of insulin sensitivity in HCV patients. Intern Med J 2010;40:503-511
19. Conjeevaram HS, Kleiner DE, Everhart JE, et al.; Virahep-C Study Group. Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 2007;45:80-87 (Pubitemid 46144367)
20. Fattovich G, Covolo L, Pasino M, et al.; Italian Hepatitis C Cohort Study Collaborative Group. The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients. Liver Int 2011;31:66-74
21. Romero-Gómez M, Diago M, Andrade RJ, et al.; Spanish Treatment of Resistance to Insulin in Hepatitis C Genotype 1 Group. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology 2009;50:1702-1708
22. Douglas MW, George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol 2009;15:4356-4364
23. Kawaguchi Y, Mizuta T, Oza N, et al. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C. Liver Int 2009;29:871-877
24. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-3578 (Pubitemid 32755946)
25. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-2776 (Pubitemid 28493774)
26. Imano E, Kanda T, Ishigami Y, et al. Interferon induces insulin resistance in patients with chronic active hepatitis C. J Hepatol 1998;28:189-193 (Pubitemid 28116425)
27. Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989;38:641-647 (Pubitemid 19125614)
28. Conjeevaram HS, Wahed AS, Afdhal N, Howell CD, Everhart JE, Hoofnagle JH; Virahep-C Study Group. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology 2011;140:469-477
29. Milner K, van der Poorten D, Trenell M, et al. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. Gastroenterology 2010;138:932-941